Premium
Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing
Author(s) -
Patil Sanjeev,
Holt Graeme,
Raby Nigel,
McLellan Alastair R.,
Smith Karen,
O'Kane Sarah,
Beastall Graham,
Crossan James F.
Publication year - 2009
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.20572
Subject(s) - medicine , simvastatin , bone mineral , randomized controlled trial , bone healing , bone density , placebo , bone remodeling , prospective cohort study , urology , surgery , osteoporosis , pathology , alternative medicine
Although statins are widely prescribed as cholesterol‐lowering drugs, a number of studies suggest that these compounds may have anabolic effects on bone. Our aim was to assess whether simvastatin affects the rate of fracture healing in humans. A prospective, double‐blind, randomized controlled trial was performed. Individuals who had sustained an undisplaced, extra‐articular fracture of the distal radial metaphysis were recruited from a trauma clinic. Patients were randomized to receive simvastatin 20 mg once daily or a placebo. Regular clinical and radiological follow‐up was undertaken for a 12 week period. Dual‐energy X‐ray absorptiometry assessment of bone mineral density was conducted at 2 and 12 weeks postinjury. Biochemical markers of bone turnover were assayed during the study period. Time to fracture union was defined as the time to cortical bridging in four cortices on plain radiographs. In addition, the rate of trabecular union was assessed. Eighty patients were recruited, of which 62 completed the study (31 in each group). Study cohorts were matched for age and gender. For patients receiving simvastatin therapy, the mean time to fracture union was 71.6 days (SD 22.2 days, SEM 3.8 days). This compared to 71.3 days (SD 21.3, SEM 4.1 days) for the control cohort ( p = 0.6481). There was no significant difference between bone mineral density or bone biochemical markers between groups ( p > 0.05). Despite promising results from in vivo and in vitro animal studies, simvastatin at a treatment dose of 20 mg once daily does not affect the rate of fracture healing in humans. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:281–285, 2009